PharmiWeb.com - Global Pharma News & Resources

Articles

In the ever-evolving field of pharmaceutical research and development, staying abreast of the latest trends and advancements is paramount. This year, the pharmaceutical industry is marked by groundbreaking innovations, regulatory shifts and unprecedented challenges. From cutting-edge technologies to novel therapeutic approaches, pharmaceutical research, and pharmaceutical approvals in 2024 are redefining how we perceive health care.
In the ever-evolving field of pharmaceutical research and development, staying abreast of the latest trends and advancements is paramount. This year, the pharmaceutical industry is marked by groundbreaking innovations, regulatory shifts and unprecedented challenges. From cutting-edge technologies to novel therapeutic approaches, pharmaceutical research, and phar…
Investing in life science companies is both challenging and rewarding. The sector is constantly evolving and comes with a lot of unknowns and risks, especially at the commercialisation stage. However, with the potential to help create a positive impact to society and simultaneously receive financial gains, it can be an incredibly worthwhile venture.
Investing in life science companies is both challenging and rewarding. The sector is constantly evolving and comes with a lot of unknowns and risks, especially at the commercialisation stage. However, with the potential to help create a positive impact to society and simultaneously receive financial gains, it can be an incredibly worthwhile venture. Launched in May 2022 by thriving life science community Discovery Park, Discovery Park Ventures…
This year, the United States expects to tally more than two million new cancer diagnoses— a first-ever prediction— and more than 611,000 cancer-related deaths. While the death rate from cancer is going down, largely due to improvements in early diagnosis and healthy lifestyle changes, the problem is that fewer people aren’t dying of cancer; that’s because the more people who are diagnosed, statistically the more who will die.
This year, the United States expects to tally more than two million new cancer diagnoses— a first-ever prediction— and more than 611,000 cancer-related deaths. While the death rate from cancer is going down, largely due to improvements in early diagnosis and healthy lifestyle changes, the problem is that fewer people aren’t dying of cancer; that’s because the more peop…
Reviewing the findings of new research into the pharma industry’s evolving aspirations for AI and intelligent automation, ArisGlobal’s Emmanuel Belabe talks to PharmiWeb about how far companies have come with smart transformation of key Safety & Regulatory processes. The international study, of 80+ organisations, spanned every patient treatment process domain, from CROs to young biotechs.
Lucy Walters, PharmiWeb (LW): What stood out most for you in the ArisGlobal 2024 Industry Survey Report[1] findings? Emmanuel Belabe, ArisGlobal (EB): The gap between use and intention. Although 75%+ of surveyed organisations claim they already use some form of ‘advanced automation’ within their processes today - up 13% from 2022 and just 5% in 2020, only 8% have applied next-generation capabilities in “al…
There is a pressing need for national and international institutions to do as much as possible to improve access to IVDs. Early diagnosis through the use of IVDs plays a critical role in patient outcomes and in supporting the healthcare system as a whole. Early interventions prevent chronicization of diseases, resulting in lower treatment costs for health systems and lessening the impact on resources and budgets.
There is a pressing need for national and international institutions to do as much as possible to improve access to IVDs. Early diagnosis through the use of IVDs plays a critical role in patient outcomes and in supporting the healthcare system as a whole. Early interventions prevent chronicization of diseases, resulting in lower treatment costs for health systems and lessening the…
Optimize your clinical trials with Clinion RTSM software the easy-to-use and innovative solution that puts patient safety and accurate randomization first
We at Clinion are excited to share our all-in-one Randomization and Trial Supply Management (RTSM) software designed to streamline clinical trial operations! Effortless Integration: Our RTSM seamlessly integrates with our EDC platform. Randomize patients and assign investigational product kits directly within the same system, eliminating the need to switch between applications and reducing the risk of data entry errors. Flexible Randomization Power: Clinion's RTSM caters to diverse study designs. Whether you require simple randomization or complex stratified/minimization approaches, our software can handle it! Real-ti…
AI is transforming medical coding by improving coding accuracy. In this blog, we’ll explore what this transformation means for clinical trial organizations.
Accuracy in medical coding is a vital aspect in aiding clinical trial operation success. It has presented an excellent opportunity for medical coders, working hand-in-hand with AI-enhanced computer-assisted coding systems, to quickly identify and validate the correct codes. Using natural language processing (NLP) and advanced Machine Learning algorithms, AI is transforming medical coding by improving coding accuracy. In this blog, we’ll explore what this transformation means for clinical trial organizations. What is Medical Coding? Medical coding is a critical process that involves assigning standardized codes to medical terms in clinic…
Clinion electronic data capture (EDC) software uses AI to simplify Study Build and set up your study in days instead of weeks with an easy-to-use interface
The Freedom And Flexibility To Built Studies On Your Own Clinion Electronic Data Capture (EDC) Software uses AI and Automation to simplify Study Build, Data Capture and Clinical Data Management (CDM). With advanced features like Medical Coding Automation, External Data Load, Visit Scheduling, Bulk locks, CRF versioning as part of a standard package Clinion makes things simpler for its users. Integrate Clinion Electronic Data Capture (EDC) Software with Clinion CTMS, IWRS/RTSM, and ePRO/eCOA for true end-to-end support of your Study, obviating the hassles of data reconciliation while dealing with multiple eCl…
Research from Teva Pharmaceuticals shows that Europe’s critical medicine cabinets – in hospitals, pharmacies, and homes – are home to fewer generic medicines. These are the often-cheaper alternatives to brand name medicines, that make up 67%[1] of all medicines.
Amsterdam, 3 April 2024 – Research from Teva Pharmaceuticals shows that Europe’s critical medicine cabinets – in hospitals, pharmacies, and homes – are home to fewer generic medicines. These are the often-cheaper alternatives to brand name medicines, that make up 67%[1] of all medicines. Over the last ten years, the number of generic medicines withdrawn from the market increased by 12%, while on average 3% fewer generics products were launched. In other words, on 31 December 2012, there were 40 280 separate generic products and 10 y…
The relationships between human health and the gut microbiota continue to intrigue researchers worldwide. Recent studies have delved deeper into understanding how dietary components can influence the composition and function of gut microbes, potentially impacting overall health.
The relationships between human health and the gut microbiota continue to intrigue researchers worldwide. Recent studies have delved deeper into understanding how dietary components can influence the composition and function of gut microbes, potentially impacting overall health. Among the latest focal points is the effect of kojic glucosylceramides on intestinal microbes in humans. While experts have long recognized kojic acid for its various biological properties, its potential interaction with gut microbiota and…
Global ambulance services market is projected to witness a CAGR of 9.71% during the forecast period 2024–2031, growing from USD 48.72 billion in 2023 to USD 102.21 billion in 2031.
Global ambulance services market is projected to witness a CAGR of 9.71% during the forecast period 2024–2031, growing from USD 48.72 billion in 2023 to USD 102.21 billion in 2031. The ambulance service industry is experiencing growth due to several reasons. One of them is the aging population, which is more susceptible to chronic diseases like obesity, diabetes, and heart disease. Another contributing factor is the shortage of primary care providers and clinics, which results in an increased reliance on emergency services. Furthermore, there is a rise in chronic diseases, trau…
Shopify Plus offers huge benefits to scale up your enterprise-level eCommerce business. Read the blog to know the importance of Shopify Plus store development
In today’s world of eCommerce, large-scale businesses are looking for robust solutions and unique platforms to stay on top of the competition. Moreover, managing eCommerce enterprises is quite difficult, specifically those having huge requirements and planning to scale up rapidly. Shopify Plus and its customized services help you manage your eCommerce business effortlessly. It offers a comprehensive range of advanced capabilities and features that allow businesses to scale and boost their digital presence. In this blog, we will discuss the prime benefits of Shopify plus development stores for eCommerce enterprises.   What is Shop…
Low-pass whole genome sequencing refers to shallow whole genome sequencing, the process of sequencing an individual's genome at a lower depth, typically around 0.1x to 5x coverage, as compared to the standard depth of 30x to 50x in traditional whole genome sequencing. This reduction in coverage significantly decreases the cost and time required for analysis while still providing valuable genomic information.
What is low-pass whole genome sequencing? In the rapidly advancing field of genomics, whole genome sequencing has become a powerful tool for deciphering the genetic blueprint of an individual. While traditional whole genome sequencing involves deep coverage to capture every base pair of an individual's genome, a newer approach known as shallow whole genome sequencing, or low-pass whole…
Gene transcription requires the unraveling of a higher structural part of the DNA. This part of the chromatin is called accessible chromatin region and this process is achieved mainly by the modification of chromosomal histones (especially acetylation). The property of chromatin is called chromatin accessibility, so that chromatin accessibility reflects the state of binding of regulatory factors to open chromatin, which is closely related to transcriptional regulation. ATAC-seq technique uses Tn5 transposase to cleave regions of DNA that are not protected by binding proteins, and is used to analyze chromatin openness and to determine dynamic changes in chromatin structure.
Gene transcription requires the unraveling of a higher structural part of the DNA. This part of the chromatin is called…